Trupanion’s first quarter saw a significant positive market response, reflecting management’s emphasis on adjusted operating income (AOI) growth, operational discipline, and expanding pet coverage. CEO Margi Tooth highlighted adjusted operating income as a key driver, noting its 29% year-over-year increase, which enabled continued investment in member acquisition and technology. Management discussed how broadening product flexibility and increasing efficiency have supported durable per-pet economics, while also citing the positive impact of new pet additions and improved retention rates.

Is now the time to buy TRUP? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Trupanion’s Q1 Earnings Call

• Wilma Burdis (Raymond James) asked about the disconnect between the 30% increase in hospitals using Trupanion software and slower pet count growth. CEO Margi Tooth explained this reflects a wider footprint but lower productivity per hospital, which is expected to improve as hospital engagement deepens over time.
• Wilma Burdis (Raymond James) also inquired about the timeline for new product adoption and details on coinsurance and deductible changes. Tooth described encouraging early results from broader coverage options and outlined a digital-first product launch targeting new customer segments, especially younger pet owners.
• Josh Shanker (Bank of America) questioned the relevance of internal rate of return (IRR) disclosures. Tooth said IRR is less meaningful now due to product mix complexity, emphasizing AOI as the best metric for evaluating returns on marketing and product investments.
• Josh Shanker (Bank of America) further asked how to assess the value of new ventures like Lands’ Path and Sainsbury’s Pet Insurance. CFO Fawwad Qureshi pointed to AOI growth as the key signpost for measuring the effectiveness of reinvestment in diverse products and geographies.
• Skye (Piper Sandler, for David Wesselberg) queried about trends in pet adoption and the shift toward more cats in the portfolio. Tooth confirmed growing cat enrollments, attributed to broader industry trends, but maintained that Trupanion’s opportunity remains sizable given the volume of pets entering veterinary systems each month.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be monitoring (1) the adoption rates and customer response to Trupanion’s new digital-first product, (2) the impact of expanded pricing options on member growth and retention, and (3) measurable improvements in operational efficiency from technology investments. Progress on international market expansion and continued gains in automated claims processing will also be key indicators of execution.

Trupanion currently trades at $24.93, up from $23.99 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.